Psychiatry Research
Volume 109, Issue 2 , Pages 137-142 , 15 March 2002

Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol

  • Hidehisa Yamashita

      Affiliations

    • Department of Psychiatry and Neurosciences, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan
    • Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST), Tokyo, Japan
    • ,
  • Shigeru Morinobu

      Affiliations

    • Department of Psychiatry and Neurosciences, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan
    • Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST), Tokyo, Japan
    • ,
  • Shigeto Yamawaki

      Affiliations

    • Department of Psychiatry and Neurosciences, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan
    • Core Research for Evolutional Science and Technology (CREST) of Japan Science and Technology Corporation (JST), Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-82-257-5208; fax: +81-82-257-5209
    • ,
  • Jun Horiguchi

      Affiliations

    • Department of Psychiatry, Shimane Medical University, Shimane, Japan
    • ,
  • Masatsugu Nagao

      Affiliations

    • Nagao Mental Hospital, Nagao, Japan

Received 27 April 2001 ,Revised 2 January 2002 ,Accepted 16 January 2002.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press; 1994;
  2. Benson KL, Csernansky JG, Zarcone VP. The effect of ritanserin on slow wave sleep deficits and sleep continuity in schizophrenia. Sleep Research. 1991;20:170 [Abstract]
  3. Benson KL, Zarcone VP. Rapid eye movement sleep and eye movements in schizophrenia and depression. Archives of General Psychiatry. 1993;50:474–482
  4. Cianchetti C, Masala C, Mangoni A, Gessa GL. Suppression of REM and delta sleep by apomorphine in man: a dopamine mimetic effect. Psychopharmacology. 1980;67:61–65
  5. Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, et al. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology. 1993;13:25–40
  6. Davenne D, Dugovic C, Franc B, Adrien J. Ontogeny of slow wave sleep. In:  Wauquier A,  Dugovic C,  Radulovacki M editor. Slow Wave Sleep: Physiological, Pathological and Functional Aspects. New York: Raven Press; 1989;p. 21–30
  7. Declerk AC, Wauquier A, Van der Ham-Veltman PHM, Gelders Y. Increase in slow-wave sleep in human with the serotonin-5HT2 antagonist ritanserin (the first exploratory polygraphic study). Current Therapeutic Research: Clinical and Experimental. 1987;41:427–432
  8. Dugovic C, Wauquier A, Janssen PAJ. Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat. Neuropharmacology. 1989;28:1431–1433
  9. Dugovic C, Wauquier A, Leysen JE, Marrannes R, Janssen PA. Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology. 1989;97:436–442
  10. Dursun SM, Patel JK, Burke JG, Reveley MA. Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. Journal of Psychiatry and Neuroscience. 1999;24:333–337
  11. Galarraga E, Corsi-Cabrera M, Sangri M. Reduction in paradoxical sleep after l-dopa administration in rats. Behavior and Neural Biology. 1986;46:249–256
  12. Ganguli R, Reynolds CF, Kupfer DJ. Electroencephalographic sleep in young, never-medicated schizophrenics: a comparison with delusional and nondelusional depressives and with healthy controls. Archives of General Psychiatry. 1987;44:36–44
  13. Idzikowski C, Mills FJ, Glennard R. 5-Hydroxytryptamine-2-antagonist increases human slow wave sleep. Brain Research. 1986;378:164–168
  14. Jus K, Beland C, Bouchard M, Jus A, Fontaine P, Brunelle R. Polygraphic night sleep pattern during chronic single and multiple neuroleptic dose administration. International Pharmacopsychiatry. 1975;10:58–63
  15. Kaplan J, Dawson S, Vaughan T, Green R, Wyatt RJ. Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics. Archives of General Psychiatry. 1974;31:62–66
  16. Katsuda Y, Walsh AE, Ware CJ, Cowen PJ, Sharpley AL. Meta-chlorophenylpiperazine decreases slow-wave sleep in humans. Biological Psychiatry. 1993;33:49–51
  17. Lawlor BA, Newhouse PA, Balkin TJ, Molchan SE, Mellow AM, Murphy DL, et al. A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers. Biological Psychiatry. 1991;29:281–286
  18. Lee JH, Woo JI, Meltzer HY. Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia. Psychiatry Research. 2001;103:157–166
  19. Maixner S, Tandon R, Eiser A, Taylor S, DeQuardo JR, Shipley J. Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension. American Journal of Psychiatry. 1998;155:1600–1602
  20. Orzack MH, Hartman EL, Kornetsky C. The relationship between attention and slow wave sleep in schizophrenia. Psychopharmacology Bulletin. 1977;13:59–61
  21. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports. 1962;10:799–812
  22. Paiva T, Arriaga F, Wauquier A, Lara E, Largo R, Leitao JN. Effects of ritanserin on sleep disturbances of dysthymic patients. Psychopharmacology. 1988;96:395–399
  23. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring Systems for Sleep Stages of Human Subjects. Los Angeles: UCLA Brain Information Services/Brain Research Institute; 1968;
  24. Sharpley AL, Vassalo CM, Cowen PJ. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo. Biological Psychiatry. 2000;47:468–470
  25. Svensson K, Alfoldi P, Hajos M, Rubicsek G, Johansson AM, Carlsson A, et al. Dopamine autoreceptor antagonists: effects on sleep–wake activity in the rat. Pharmacology, Biochemistry and Behavior. 1987;26:123–129
  26. Tandon R, Shipley JE, Greden JF, Mann NA, Eisner WH, Goodson JA. Electroencephalographic sleep abnormality in schizophrenia: relationship to positive/negative symptoms and prior neuroleptic treatment. Archives of General Psychiatry. 1992;49:185–194

PII: S0165-1781(02)00009-4

Psychiatry Research
Volume 109, Issue 2 , Pages 137-142 , 15 March 2002

Article Tools